Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NATCO PHARMA LTD

  • FDA Approval
  • Sept. 20, 2024, 08:42 UTC
  • 46
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

APPCO

  • FDA Approval
  • Sept. 20, 2024, 08:42 UTC
  • 44
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 38
  • 0 comments

FDA approve NETARSUDIL MESYLATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 39
  • 0 comments

FDA approve ATENOLOL

Comment Full text

MSN

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 42
  • 0 comments

FDA approve PRAZOSIN HYDROCHLORIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 45
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

COREPHARMA

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 44
  • 0 comments

FDA approve DEXAMETHASONE

Comment Full text

BARR

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 55
  • 0 comments

FDA approve MEDROXYPROGESTERONE ACETATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 43
  • 0 comments

FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

XTTRIUM LABS INC

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 40
  • 0 comments

FDA approve LACTULOSE

Comment Full text
  • Previous
  • 351
  • 352
  • 353
  • 354
  • 355
  • Next

Search

News categories

  • Technical Exchange News(11551)
  • Event(3509)
  • SEC News(218266)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(138285)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin